Pricing Log in Create free account

Citius Oncology, Inc. (CTOR) vs Rockwell Medical, Inc. (RMTI)

Citius Oncology, Inc. and Rockwell Medical, Inc. are both Drug Manufacturers Specialty & Generic companies. Citius Oncology, Inc. is the larger, with a market value of $46.5M against $30.6M — 1.5× the size. Citius Oncology, Inc. has the higher net margin (0.00% vs −7.33%) and the lower return on invested capital (−67.2% vs −14.6%). Across the 13 metrics below, Rockwell Medical, Inc. leads on 9 and Citius Oncology, Inc. on 4.

Valuation

Metric CTOR RMTI Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S n/m 0.44 2.08
P/B 1.36 0.87 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m 0.21 2.87
Earnings yield (92.16%) (17.40%) (15.94%)
Free cash flow yield (58.41%) (3.22%) 0.00%

Profitability

Metric CTOR RMTI Drug Manufacturers Specialty & Generic median
Gross margin — 17.71% 53.51%
Operating margin 0.00% (6.52%) 0.00%
Net margin 0.00% (7.33%) (2.45%)
Free cash flow margin 0.00% 2.47% 0.00%
Return on equity (126.58%) (15.53%) (0.80%)
Return on assets (45.20%) (9.32%) (1.67%)
Return on invested capital (67.15%) (14.58%) 0.00%

Growth

Metric CTOR RMTI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (21.12%) 5.22%
EPS growth (last fiscal year) (9.68%) (870.87%) 42.91%
Revenue growth, 5-year CAGR — 2.17% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTOR RMTI Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 0.26 0.04
Current ratio 0.73 3.25 2.41
Net debt to EBITDA (0.40) 7.40 1.01

Dividend

Metric CTOR RMTI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric CTOR RMTI Drug Manufacturers Specialty & Generic median
Market cap 46.50m 30.64m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack